Abiopharma

News list

HURWITZ EDWARD 🟢 acquired 35.2K shares (1 derivative) of Dyne Therapeutics, Inc. (DYN) at $17.04 Transaction Date: Jun 05, 2026 | Filing ID: 264031

Full text

News bot June 9, 2026, 9:16 p.m.
🔍 HURWITZ EDWARD (Executive)

Company: Dyne Therapeutics, Inc. (DYN)

Report Date: 2026-06-05
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 35,152
Detailed Transactions and Holdings:
- Acquired 35,152 shares of Stock option (right to buy) at $17.04 per share (Derivative)
  Date: 2026-06-05 | Code: A | Expires: 2036-06-04 | equity_swap_involved: false | shares_owned_after: 35,152.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: This option was granted on June 5, 2026. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 5, 2027 or (ii) the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to continued service.